Sentence examples for marker expression analysis from inspiring English sources

Characterisation of tumour stem-like cells in vitro was performed using self-renewal assays, stem cell-associated marker expression analysis, differentiation, and stimulated hormone production assays.

In all, 12 GBM patients (44%) and 11 grade 3 malignant glioma patients (34%) had adequate tumour material for marker expression analysis (Supplementary Table 1, Supplementary Figure 1).

Although the chondrogenic marker expression analysis did not reveal variations in the gene expression levels of the BGN (biglycan), LUM (lumican) was found to be upregulated on the 21st day of culture.

Using retrograde labeling, molecular marker expression analysis, and adeno-associated virus (AAV -mediated AAV -mediatednd retrogranterogradection, we demonstrand earetrogradetransductionssive, and profound CSMN degeneration in the absence of UCHL1 function.

Marker expression analysis of the dominant tumor subtypes revealed mixed expression of smooth muscle actin (SMA) and cytokeratin 5 (K6), K14 K14 (basal markers), K18 (luminal marker), vimentin, ERα, as well as nuclear co-localization of β-catenin and cyclin D2 (Supplementary Fig S1), a pattern often found in other tumor models of mixed lineages such as MMTV-WNT1 (Li et al, 2003).

(D) M1/M2 macrophage marker gene expression analysis in fed and fasted (24 h) mice.

(F) M1/M2 macrophage marker gene expression analysis after acute adipose-VEGF upregulation in VEGFAdipoq-Tg mice.

(A) M1/M2 macrophage marker gene expression analysis in HFD-AL and -IF mice.

Additional alterations to knee joint associated tissues were revealed through marker gene expression analysis.

C2C12 cells cultured in the growth medium were treated with PD98059 or DMSO for 24 h, and cells were subsequently either subjected to cell cycle analysis or total RNA extraction for miR-133 and myogenic marker gene expression analysis.

In conclusion, information regarding DNA methylation derived from mouse EShypo-T-DMRs is a feasible index for evaluation of porcine iPSCs as a pre-screening tool, distinct from morphology and marker gene expression analysis.